Trusted Resource for Clinical Trials, Protocols & Progress
Assessing Protocol Deviations in Past Trials Assessing Protocol Deviations in Past Clinical Trials for Site Qualification Introduction: The Impact of Protocol Deviations on Site Evaluation Protocol deviations (PDs) are critical indicators of a clinical trial site’s operational discipline, training adequacy, and regulatory compliance. Reviewing historical deviation patterns across a site’s prior trials enables sponsors and…
Using Deviation Metrics to Customize Training Programs How Deviation Metrics Drive Customized and Effective Training Programs Introduction: Why One-Size-Fits-All Training Fails In clinical research, protocol deviations are inevitable—but repeated or systemic deviations reflect deep gaps in training and oversight. Traditional blanket training programs often fail to resolve these issues. A smarter, risk-based approach involves using…
Read More “Using Deviation Metrics to Customize Training Programs” »
Targeted Monitoring Triggered by Protocol Deviations How Protocol Deviations Trigger Targeted Monitoring in Clinical Trials Introduction: When Deviations Signal Oversight Gaps Protocol deviations are more than isolated compliance errors—they often serve as early warning signals of systemic gaps in clinical trial conduct. Regulatory agencies such as the FDA, EMA, and MHRA increasingly expect sponsors to…
Read More “Targeted Monitoring Triggered by Protocol Deviations” »
Role of RCA in Preventing Repeat Deviations How Root Cause Analysis Prevents Repeat Deviations in Clinical Trials Understanding the Link Between RCA and Deviation Recurrence Protocol deviations are inevitable in clinical trials due to the complexity of procedures, human involvement, and real-world operational challenges. However, repeated deviations of the same type signal systemic weaknesses—often due…
Detecting SOP Deviations in Monitoring Visits How to Identify SOP Deviations During Monitoring Visits Introduction: Why Monitoring Visits Are Key to Detecting SOP Issues Site monitoring visits are critical quality control checkpoints in clinical trials. These visits are not just about source data verification—they are also opportunities to identify deviations from approved Standard Operating Procedures…
